Post-transplant, columnist Sam Kirton avoids negativity at all costs, as it's detrimental to his mental health and overall well-being.

IPF treatment SM001-055 was generally safe and improved lung function, according to top-line data from a Phase 2a trial.

Many factors helped columnist Sam Kirton know when it was time to stop working so he could better attend to his health issues with IPF.

IPF's effects are relentless, says columnist Charlene Marshall, who faced various knee surgery complications because of her lung disease.

A Phase 3 clinical trial testing Boehringer Ingelheim’s oral investigational treatment nerandomilast in people with idiopathic pulmonary fibrosis (IPF) has met its primary goal of demonstrating the ...

A University of Colorado professor has won the 2024 Alton Ochsner Award Relating Smoking and Disease for his work into how genetic and environmental factors, including smoking, contribute to a ...

At the end of this week, I will complete another trip around the sun. This seemed like an appropriate time to provide you with updates on several columns I have shared in the past year. When I was ...

When I was diagnosed with idiopathic pulmonary fibrosis (IPF) in January 2017, the disease was a mystery to me. I’ve shared before that when my wife, Susan, and I left the clinic following my ...